PACKAGE LEAFLET: INFORMATION FOR THE USER
Page 1 of 6 Package leaflet: Information for the user Zinforo ® 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil
Download PACKAGE LEAFLET: INFORMATION FOR THE USER
Information
Domain:
Source:
Link to this page:
Documents from same domain
Package leaflet: Information for the user Clexane …
www.medicines.org.uk1 Package leaflet: Information for the user. Clexane® Syringes 2,000 IU (20 mg)/0.2 ml solution for injection in pre-filled syringes . Clexane® Syringes 4,000 IU (40 mg)/0.4 ml solution for injection in pre-filled syringes
small pharma code may appear on the front / back …
www.medicines.org.ukKeep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the blister and carton after EXP.
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1. Package Leaflet 1 PACKAGE LEAFLET: INFORMATION FOR THE USER CALCEOS 500mg/400IU CHEWABLE TABLETS …
PACKAGE LEAFLET: INFORMATION FOR THE USER
www.medicines.org.uk1.3.1 Package Leaflet 1 Package leaflet: Information for the patient Laxido Orange, powder for oral solution. Read all of this leaflet carefully before you start taking this medicine because it contains
Package leaflet: Information for the user - Medicines
www.medicines.org.ukPage 1 of 8 v019_0 Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack.
Package leaflet: Information for the user …
www.medicines.org.ukRead all of this leaflet carefully before you start taking this medicine because it contains important information for you. • Keep this leaflet.
PFIZER Package leaflet: Information for the patient …
www.medicines.org.ukPage 1 of 20 PFIZER Package leaflet: Information for the patient Depo-Provera® 150 mg/ml Sterile Suspension for Injection Medroxyprogesterone acetate Please read all of this leaflet carefully before you start using this medicine because it
SAYANA PRESS 104 mg/0.65 ml suspension for …
www.medicines.org.ukPage 1 of 15 Package leaflet: Information for the user SAYANA PRESS® 104 mg/0.65 ml suspension for injection medroxyprogesterone acetate Single-dose container ...
PACKAGE LEAFLET: INFORMATION FOR THE USER …
www.medicines.org.ukPACKAGE LEAFLET: INFORMATION FOR THE USER Bisoprolol 2.5 mg Film-coated Tablet Bisoprolol 5 mg Film-coated Tablet Bisoprolol 10 mg Film-coated Tablet
Patient Information Leaflet - Medicines
www.medicines.org.ukPage 2 of 10 Patient Information Leaflet Salazopyrin® EN-tabs 500 mg enteric-coated tablets sulfasalazine In this leaflet: 1. What Salazopyrin EN …
Related documents
FLOSEAL Hemostatic Matrix, 5 mL
floseal.comFLOSEAL Hemostatic Matrix, 5 mL Instructions for Use Caution: Federal Law (United States) restricts this device to sale by or on the order of a licensed healthcare practitioner.
AEROSPACE MEDICAL SERVICE SPECIALTY …
static.e-publishing.af.milqtp 4n0x1-2 . july 2014 . aerospace medical service specialty . nursing care of patients with special needs . total force, total care – everytime, anywhere
Product Information Plasma-Lyte 148 Replacement …
www.baxterhealthcare.com.auPlasma-Lyte 148 Replacement PI 05Jul2013 Page 3 of 8 ccsi41920130326 Baxter In patients with diminished renal function, administration of Plasma-Lyte 148 Replacement IV Infusion may
PRODUCT INFORMATION SODIUM CHLORIDE …
www.baxterhealthcare.com.auPI_0.9% Sodium Chloride (AVIVA)_22Oct 2013 4 When selecting the type of infusion solution and the volume/rate of infusion for a elderly patient,
Data Sheet 3% Citanest DENTAL with Octapressin
www.medsafe.govt.nzData Sheet. 3% Citanest ® DENTAL. with Octapressin ® Prilocaine 30 mg/mL, felypressin 0.54 µg/mL. Presentation. 3% Citanest® DENTAL with Octapressin® solution for injection is a sterile isotonic aqueous
Platelet Additive Solutions (PAS) - SEABB
www.seabb.orgPlatelet Additive Solutions (PAS) Jose Lima, MD Medical Director, Southern Region March 2012
Patient Safety Solutions | volume 1, solution 1 | …
www.who.intWHO Collaborating Centre for Patient Safety Solutions Aide Memoire Statement of Problem and ImPact: The existence of confusing drug names is one of the most com-
Patient Safety Solutions | volume 1, solution 3 | …
www.who.intWHO Collaborating Centre for Patient Safety Solutions Aide Memoire Statement of Problem and ImPact: During an episode of disease or period of care, a patient can
Related search queries
FLOSEAL Hemostatic Matrix, 5 mL, AEROSPACE MEDICAL SERVICE SPECIALTY, Aerospace medical service specialty . nursing, Product Information Plasma-Lyte 148 Replacement, PRODUCT INFORMATION SODIUM CHLORIDE, Solution, Volume, Patient, Prilocaine, Platelet Additive Solutions PAS, Patient Safety Solutions, Volume 1, Solution 1, Patient Safety Solutions | volume 1, solution 3 |